Scalable MSCI AC World Xtrackers UCITS ETF 1C

INVESTMENT OBJECTIVE: The aim is for your investment to reflect the performance of the MSCI ACWI Index (index) which is designed to reflect the performance of the shares of large and medium capitalisation companies in global developed and emerging market countries. The sub-portfolio manager for the fund is DWS Investments UK Limited. DWS Investments UK Limited has appointed Scalable Capital GmbH (Portfolio Construction Advisor) to provide advisory services with regard to the construction of the portfolio (Proposed Composition). DESCRIPTION OF INDEX: The selection universe of the index includes large and medium capitalisation listed equity securities from developed and emerging market countries globally. A company's weighting in the index depends on its relative size. INDEX REBALANCING, CALCULATION AND ADMINISTRATION: The fund tracks a version of the index which is calculated in USD on an end of day basis. The index is reviewed and rebalanced quarterly. The index is calculated on a total return net basis which means that all dividends and distributions by the companies are reinvested in the shares after tax. The index is administered by MSCI Limited. INVESTMENT POLICY: To achieve the investment objective, the fund may invest in a variety of assets and/or instruments which may comprise: all or a representation of the equity securities comprised in the index, other transferablee securities, UCITS or other UCIs, including but not limited to funds of Xtrackers and Xtrackers (IE) plc, which are traded on a regulated market, and enter into financial contracts (derivatives) with one or more swap counterparties relating to the transferable securities and the index and/or other eligible financial indices that are closely related to the index, in order to obtain the return on the index. FURTHER INFORMATION: Certain information (including the latest share prices of the fund, indicative net asset values, full disclosure on the composition of the fund's portfolio and informati

Physical replication

PIR compliant

No

PEA compliant

No

PEA-PME compliant

No